Prediction of adverse outcomes in children with sickle cell anemia

A study of the Dallas Newborn Cohort

Charles T. Quinn, Nancy J. Lee, Elizabeth P. Shull, Naveed Ahmad, Zora R. Rogers, George R. Buchanan

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The Cooperative Study of Sickle Cell Disease reported that dactylitis, severe anemia, and leukocytosis in very young children with sickle cell disease (SCD) increased the risk of later adverse outcomes, including death, stroke, frequent pain, and recurrent acute chest syndrome. This model has not been validated in other cohorts. We evaluated its performance in the Dallas Newborn Cohort, a newborn inception cohort of children with SCD. We studied 168 children (55% male, 97% sickle cell anemia) with a mean follow-up of 7.1 years who provided 1188 patient-years of observation. Of the 23 (13.7%) subjects who experienced adverse events, 2 (1.2%) died, 14 (8.3%) had a stroke, 4 (2.4%) had frequent pain, and 3 (1.8%) had recurrent acute chest syndrome. No relationship existed between early clinical predictors and later adverse outcomes, with the possible exception of leukocyte count. Most subjects who experienced adverse events were predicted to be at low risk for those events. No subject who was predicted to be at high risk actually experienced an adverse outcome. The sensitivity of the model did not rise above 20% until specificity fell below 60%. We suggest that this model not be used as a criterion to initiate early interventions for SCD.

Original languageEnglish (US)
Pages (from-to)544-548
Number of pages5
JournalBlood
Volume111
Issue number2
DOIs
StatePublished - Jan 15 2008

Fingerprint

Sickle Cell Anemia
Newborn Infant
Acute Chest Syndrome
Stroke
Pain
Leukocytosis
Leukocyte Count
Anemia
Observation

ASJC Scopus subject areas

  • Hematology

Cite this

Prediction of adverse outcomes in children with sickle cell anemia : A study of the Dallas Newborn Cohort. / Quinn, Charles T.; Lee, Nancy J.; Shull, Elizabeth P.; Ahmad, Naveed; Rogers, Zora R.; Buchanan, George R.

In: Blood, Vol. 111, No. 2, 15.01.2008, p. 544-548.

Research output: Contribution to journalArticle

Quinn, Charles T. ; Lee, Nancy J. ; Shull, Elizabeth P. ; Ahmad, Naveed ; Rogers, Zora R. ; Buchanan, George R. / Prediction of adverse outcomes in children with sickle cell anemia : A study of the Dallas Newborn Cohort. In: Blood. 2008 ; Vol. 111, No. 2. pp. 544-548.
@article{ce479f4d9efb46a78e65c3814ec3410f,
title = "Prediction of adverse outcomes in children with sickle cell anemia: A study of the Dallas Newborn Cohort",
abstract = "The Cooperative Study of Sickle Cell Disease reported that dactylitis, severe anemia, and leukocytosis in very young children with sickle cell disease (SCD) increased the risk of later adverse outcomes, including death, stroke, frequent pain, and recurrent acute chest syndrome. This model has not been validated in other cohorts. We evaluated its performance in the Dallas Newborn Cohort, a newborn inception cohort of children with SCD. We studied 168 children (55{\%} male, 97{\%} sickle cell anemia) with a mean follow-up of 7.1 years who provided 1188 patient-years of observation. Of the 23 (13.7{\%}) subjects who experienced adverse events, 2 (1.2{\%}) died, 14 (8.3{\%}) had a stroke, 4 (2.4{\%}) had frequent pain, and 3 (1.8{\%}) had recurrent acute chest syndrome. No relationship existed between early clinical predictors and later adverse outcomes, with the possible exception of leukocyte count. Most subjects who experienced adverse events were predicted to be at low risk for those events. No subject who was predicted to be at high risk actually experienced an adverse outcome. The sensitivity of the model did not rise above 20{\%} until specificity fell below 60{\%}. We suggest that this model not be used as a criterion to initiate early interventions for SCD.",
author = "Quinn, {Charles T.} and Lee, {Nancy J.} and Shull, {Elizabeth P.} and Naveed Ahmad and Rogers, {Zora R.} and Buchanan, {George R.}",
year = "2008",
month = "1",
day = "15",
doi = "10.1182/blood-2007-07-100719",
language = "English (US)",
volume = "111",
pages = "544--548",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "2",

}

TY - JOUR

T1 - Prediction of adverse outcomes in children with sickle cell anemia

T2 - A study of the Dallas Newborn Cohort

AU - Quinn, Charles T.

AU - Lee, Nancy J.

AU - Shull, Elizabeth P.

AU - Ahmad, Naveed

AU - Rogers, Zora R.

AU - Buchanan, George R.

PY - 2008/1/15

Y1 - 2008/1/15

N2 - The Cooperative Study of Sickle Cell Disease reported that dactylitis, severe anemia, and leukocytosis in very young children with sickle cell disease (SCD) increased the risk of later adverse outcomes, including death, stroke, frequent pain, and recurrent acute chest syndrome. This model has not been validated in other cohorts. We evaluated its performance in the Dallas Newborn Cohort, a newborn inception cohort of children with SCD. We studied 168 children (55% male, 97% sickle cell anemia) with a mean follow-up of 7.1 years who provided 1188 patient-years of observation. Of the 23 (13.7%) subjects who experienced adverse events, 2 (1.2%) died, 14 (8.3%) had a stroke, 4 (2.4%) had frequent pain, and 3 (1.8%) had recurrent acute chest syndrome. No relationship existed between early clinical predictors and later adverse outcomes, with the possible exception of leukocyte count. Most subjects who experienced adverse events were predicted to be at low risk for those events. No subject who was predicted to be at high risk actually experienced an adverse outcome. The sensitivity of the model did not rise above 20% until specificity fell below 60%. We suggest that this model not be used as a criterion to initiate early interventions for SCD.

AB - The Cooperative Study of Sickle Cell Disease reported that dactylitis, severe anemia, and leukocytosis in very young children with sickle cell disease (SCD) increased the risk of later adverse outcomes, including death, stroke, frequent pain, and recurrent acute chest syndrome. This model has not been validated in other cohorts. We evaluated its performance in the Dallas Newborn Cohort, a newborn inception cohort of children with SCD. We studied 168 children (55% male, 97% sickle cell anemia) with a mean follow-up of 7.1 years who provided 1188 patient-years of observation. Of the 23 (13.7%) subjects who experienced adverse events, 2 (1.2%) died, 14 (8.3%) had a stroke, 4 (2.4%) had frequent pain, and 3 (1.8%) had recurrent acute chest syndrome. No relationship existed between early clinical predictors and later adverse outcomes, with the possible exception of leukocyte count. Most subjects who experienced adverse events were predicted to be at low risk for those events. No subject who was predicted to be at high risk actually experienced an adverse outcome. The sensitivity of the model did not rise above 20% until specificity fell below 60%. We suggest that this model not be used as a criterion to initiate early interventions for SCD.

UR - http://www.scopus.com/inward/record.url?scp=38349193738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349193738&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-07-100719

DO - 10.1182/blood-2007-07-100719

M3 - Article

VL - 111

SP - 544

EP - 548

JO - Blood

JF - Blood

SN - 0006-4971

IS - 2

ER -